Inhibikase Therapeutics Inc (IKT)
R&D Expenses
$13.39M
Quarterly · Period ending: · USD
IKT R&D Expenses
Latest reported$13.39Mperiod ending
Latest reported$13.39Mperiod ending
IKT Quarterly R&D Expenses ($256.89K → $13.39M)
Quarterly R&D Expenses
High-resolution chart · PNG
IKT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 13,393,464 | |
| 10,839,150 | |
| 6,358,903 | |
| 7,649,697 | |
| 5,270,967 | |
| 10,513,579 | |
| 7,186,999 | |
| 4,189,873 | |
| 3,075,830 | |
| 2,751,279 | |
| 3,002,980 | |
| 3,225,551 | |
| 4,535,698 | |
| 2,854,119 | |
| 3,054,158 | |
| 2,981,653 | |
| 2,982,183 | |
| 3,016,991 | |
| 3,390,258 | |
| 3,154,553 | |
| 2,382,433 | |
| 2,431,860 | |
| 226,944 | |
| 120,569 | |
| 263,175 | |
| 283,114 | |
| 267,915 | |
| 254,968 | |
| 474,047 | |
| 1,555,781 | |
| 1,461,126 | |
| 585,291 | |
| 600,121 | |
| 256,890 |